Nile Therapeutics, Inc. (OTCQB: NLTX), a biopharmaceutical company, promoted Darlene Horton, M.D. to President and CEO of the company and appointed her to the Board of Directors. Darlene had been the Chief Medical Officer of the comany. Before that Darlene was a Co-Founder of Itero Biopharmaceuticals where she helped raise $17 million in capital. Darlene completed her fellowship in Pediatric Cardiology at the Cardiovascular Research Institute at the University of California San Francisco. Read more in the prnewswire press release.